The Medicines Company to Host Conference Call and Webcast Discussing Fourth-Quarter and Full-Year 2017 Financial Results

PARSIPPANY, N.J.–(BUSINESS WIRE)–The Medicines Company (NASDAQ: MDCO) will host a conference call and
webcast on Wednesday, February 21, 2018, at 8:30 a.m., Eastern Time, to
discuss fourth-quarter and full-year 2017 financial results and
operational developments.

The conference call may be accessed by telephone as follows:

  U.S./Canada:   (877) 359-9508
International: (224) 357-2393
Conference ID: 3592738

A taped replay of the conference call will be available after the call
concludes, and may be accessed by telephone as follows:

U.S./Canada:   (855) 859-2056
International: (404) 537-3406
Conference ID: 3592738

A live audio webcast of the conference call may be accessed in the
Investors section of The Medicines Company
website. An archived
webcast will be available after the call concludes.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an
overriding purpose – to save lives, alleviate suffering and contribute
to the economics of healthcare. The Company’s goal is to create
transformational solutions to address the most pressing healthcare needs
facing patients, physicians and providers in cardiovascular care. The
Company is headquartered in Parsippany, New Jersey.

Contacts

Investor Relations
The
Medicines Company
Krishna Gorti, M.D.
Vice President, Investor
Relations
973-290-6122
krishna.gorti@themedco.com